The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of approximately 9% during the forecast period. This growth is largely driven by the ...
While the concept of a combination product is not new, these unique healthcare products (drug plus device, biological plus device, drug plus biological product, or drug plus device plus biological ...
Drug–device combination products are becoming increasingly prevalent, with many lasting years beyond the expiration date of primary and secondary patents on the drug itself. It is unknown how common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback